克洛扎宾与非血液性恶性瘤之间的关系:使用FDA不良事件报告系统数据库的药监测分析
Yuichi Uwai1, Tomohiro Nabekura2
1School of Pharmacy, Aichi Gakuin University, 1-100, Kusumoto, Chikusa, Nagoya, 464-8650, Japan. yuuwai@dpc.agu.ac.jp.
Drugs - real world outcomes
|March 31, 2024
概括
克洛沙平的使用可能与某些非血液性恶性瘤的风险增加有关,包括肺癌,胃肠癌和丸癌. 需要进一步的研究来证实美国食品和药物管理局不良事件报告系统数据库中的这些发现.
科学领域:
- 药物监督 药物监督 药物监督
- 在瘤学瘤学.
- 精神病学是一个精神病学.
背景情况:
- 克洛沙平是一种高度有效的抗精神病药物,用于治疗耐药精神分裂症.
- 克洛扎宾与非血液性恶性瘤之间的潜在关联需要进行调查.
研究的目的:
- 为了调查与克洛扎使用相关的非血液性恶性瘤的风险.
- 利用美国食品和药物管理局 (FDA) 的不良事件报告系统 (FAERS) 数据库进行分析.
主要方法:
- 从2004年第一季度到2012年第三季度的FAERS数据的不成比例分析.
- 使用标准化医疗词典对监管活动查询 (SMQ) 识别了非血液性恶性瘤.
主要成果:
- 在克洛扎使用者中,共发现了1668例非血液性恶性瘤报告.
- 克洛扎的使用与这些瘤的风险增加有关 (ROR 1.28).
- 对丸癌,胃肠癌,肺癌,喉癌以及脊柱和肝脏转移的特定风险增加.
结论:
- 该研究检测到信号,表明克洛扎宾与某些非血液性恶性瘤之间存在关联.
- 来自FAERS数据库的调查结果要求对这种潜在关联进行进一步调查.
相关概念视频
Pharmacovigilance
830
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
830
Psychosis: Goals of Pharmacotherapy
125
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
125
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
281
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
281
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
200
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
200
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


